| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000004824 |
| Receipt No. | R000005740 |
| Official scientific title of the study | Development of clinical Magnetic Resonance Imaging techniques using high field magnetic resonance |
| Date of disclosure of the study information | 2011/02/01 |
| Last modified on | 2016/07/15 (Ver. 13) |
| Basic information | ||
| Official scientific title of the study | Development of clinical Magnetic Resonance Imaging techniques using high field magnetic resonance | |
| Title of the study (Brief title) | Clinical MRI technique development | |
| Region |
|
|
| Condition | |||||||||||
| Condition | liver cirrhosis
gynecological diseases myopia donor of liver transplantation Hypertension |
||||||||||
| Classification by specialty |
|
||||||||||
| Classification by malignancy | Others | ||||||||||
| Genomic information | NO | ||||||||||
| Objectives | |
| Narrative objectives1 | Our first object is to adjust 3T MR machine located for only research that was developed at NEDO project, for clinical usage.
Secondly, providing highly advanced examination for the patients is important object by establishing the new MR taking sequences. |
| Basic objectives2 | Others |
| Basic objectives -Others | Detection of image changes related to pathophysiology. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Investigation of diagnostic capability of a new acquisition method |
| Key secondary outcomes | Evalulation of image quality and artifacts of a new acquisition method |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -but assessor(s) are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Diagnosis | ||
| Type of intervention |
|
||
| Interventions/Control_1 | taking MR imaging | ||
| Interventions/Control_2 | taking MR imaging | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patients who agreed to takiing MR images | |||
| Key exclusion criteria | Contraindication of MRI scan
Poor image quality |
|||
| Target sample size | 480 | |||
| Research contact person | |
| Name of lead principal investigator | Kaori Togashi |
| Organization | Kyoto university |
| Division name | diagnostic radiology and nuclear medicine |
| Address | 57ShogoinKawahara-cho, Sakyo, Kyoto city, Kyoto |
| TEL | 075-751-3760 |
| ktogashi@kuhp.kyoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Aki KIDO |
| Organization | Kyoto university |
| Division name | diagnostic radiology and nuclear medicine |
| Address | 57ShogoinKawahara-cho, Sakyo, Kyoto city, Kyoto |
| TEL | 075-751-3760 |
| Homepage URL | |
| akikido@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | Kyoto university |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Toshiba medical Systems Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | japan |
| Other related organizations | |
| Co-sponsor | Toshiba medical Systems Corporation |
| Name of secondary funder(s) | no |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 京都大学医学部附属病院(京都府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | Comparison of non-contrast enhanced brain angiography between FSBB and TOF |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005740 |